SEEK ID: https://armlifebank.am/people/10
Location:
Armenia
ORCID: Not specified
Joined: 14th Mar 2024
Expertise: Not specified
Tools: Not specified

This person has not yet tagged anything.
Related items
Cellular dysfunction, the fundamental basis of all human diseases, underpins the pathophysiology of numerous disorders. This program presents a overview of research initiatives focused on advancing human health through the development of diagnostic, preventive, and therapeutic strategies. These projects are conducted in collaboration with multiple research institutions and are supported by diverse grant funding mechanisms.
Projects: Study of the molecular mechanisms of familial Mediterranean fever using genetic engineering and functional genomics, Development of induced pluripotent stem cells bank of patients with Familial Mediterranean Fever
Web page: Not specified
This program is designed to encapsulate and facilitate research projects focusing on the intricate dynamics between genetic predispositions and environmental factors in the progression of chronic diseases, excluding cancer. This initiative aims to unravel the molecular mechanisms and pathways that underlie these diseases, thereby paving the way for targeted interventions and therapies.
Projects: Mental disorders and aging brain, Omics-Based Insights into Human Long-Term Exposure to Environmental Metals
Web page: Not specified
This project focuses on studies around brain disorders and ageing.
Programme: Genes, Environment and Chronic Diseases
Public web page: Not specified
Organisms: Human
In this project genetic engineering and functional genomics approaches will be used to describe molecular mechanisms of FMF. Using DNA/RNA samples obtained from FMF patients and healthy subjects MEFV nanopore gene sequencing will be performed to identify genetic variants and possibly find novel putative functional variants. The impact of genetic variants on transcriptome landscape will be studies by RNA-sequencing using nanopore sequencing device. Based on MEFV sequencing data and patients clinical ...
Programme: Cellular basis of diseases
Public web page: Not specified
Start date: 1st Sep 2021
End date: 31st Aug 2024
Organisms: Human
Abstract (Expand)
Authors: A. Stepanyan, A. Brojakowska, R. Zakharyan, S. Hakobyan, S. Davitavyan, T. Sirunyan, G. Khachatryan, M. K. Khlgatian, M. Bisserier, S. Zhang, S. Sahoo, L. Hadri, A. Rai, V. N. S. Garikipati, A. Arakelyan, D. A. Goukassian
Date Published: 28th Dec 2024
Publication Type: Journal
PubMed ID: 39732652
Citation: Cardiovasc Diabetol. 2024 Dec 28;23(1):454. doi: 10.1186/s12933-024-02565-9.
Abstract (Expand)
Authors: Varduhi Hayrapetyan, Lana Karapetyan, Lilit Ghukasyan, Sofi Atshemyan, Hovsep Ghazaryan, Valentina Vardanyan, Vahan Mukuchyan, Arsen Arakelyan, Roksana Zakharyan
Date Published: 2nd Dec 2024
Publication Type: Journal
Citation: International Journal of Molecular Sciences,25(23):12958
Abstract (Expand)
Authors: Lilit Ghukasyan, Gisane Khachatryan, Tamara Sirunyan, Arpine Minasyan, Siras Hakobyan, Andranik Chavushyan, Varduhi Hayrapetyan, Hovsep Ghazaryan, Gevorg Martirosyan, Gohar Mkrtchyan, Valentina Vardanyan, Vahan Mukuchyan, Ashot Davidyants, Roksana Zakharyan, Arsen Arakelyan
Date Published: 29th Nov 2024
Publication Type: Journal
DOI: 10.3389/fgene.2024.1493295
Citation: Frontiers in Genetics,15
Abstract (Expand)
Authors: Elena V. Grigor’eva, Lana V. Karapetyan, Anastasia A. Malakhova, Sergey P. Medvedev, Julia M. Minina, Varduhi H. Hayrapetyan, Valentina S. Vardanyan, Suren M. Zakian, Arsen Arakelyan, Roksana Zakharyan
Date Published: 1st Jun 2024
Publication Type: Journal
DOI: 10.3390/ijms25116102
Citation: International Journal of Molecular Sciences,25(11):6102
Abstract (Expand)
Authors: A. Arakelyan, S. Avagyan, A. Kurnosov, T. Mkrtchyan, G. Mkrtchyan, R. Zakharyan, K. R. Mayilyan, H. Binder
Date Published: 17th Feb 2024
Publication Type: Journal
PubMed ID: 38368435
Citation: Schizophrenia (Heidelb). 2024 Feb 17;10(1):19. doi: 10.1038/s41537-024-00443-7.
Patient-specific induced pluripotent stem cells (iPSCs) are reprogrammed somatic cells derived from individual patients through the expression of key transcription factors (e.g., OCT4, SOX2, KLF4, and c-MYC). These cells exhibit pluripotency, allowing them to differentiate into various cell types and serve as in vitro models for studying disease mechanisms, drug screening, and regenerative medicine.
Sample Name (String) *, Type (String) *, Condition (String) *, Link (String) , Location (String)
Not specified
Type: Patient-specific induced pluripotent stem cells (iPSCs)
Creators: Arsen Arakelyan, Lana Karapetyan, Roksana Zakharyan
Submitter: Arsen Arakelyan
Type: Patient-specific induced pluripotent stem cells (iPSCs)
Creators: Arsen Arakelyan, Lana Karapetyan, Roksana Zakharyan
Submitter: Arsen Arakelyan
Type: Patient-specific induced pluripotent stem cells (iPSCs)
Creators: Arsen Arakelyan, Lana Karapetyan, Roksana Zakharyan
Submitter: Arsen Arakelyan
Type: Patient-specific induced pluripotent stem cells (iPSCs)
Creators: Arsen Arakelyan, Lana Karapetyan, Roksana Zakharyan
Submitter: Arsen Arakelyan